Sarcopenia/Muscle Mass is not a Prognostic Factor for Short‐ and Long‐Term Outcome After Esophagectomy for Cancer

• DOI: 10.1007/s00268-016-3603-1
• Publication Date: 2016-06-07T23:29:51Z
• Authors: Brechtje A. Grote...; Joël Shapiro; Stefan van Adrichem; Marianne de Vries; Marcel Koek; Bas P. L. Wijnhoven; J. Jan B. van Lan...
• Keywords: Esophagectomy; Chemoradiotherapy; Sarcopenic obesity; Neoadjuvant Therapy

Recent studies have suggested that sarcopenia is a prognostic risk indicator of postoperative complications and predicts survival in cancer patients. The aim this study to investigate whether associated with short-term outcome (morbidity mortality) long-term patients undergoing esophagectomy for after neoadjuvant chemoradiotherapy.All who underwent chemoradiotherapy followed by cancer, whom an adequate CT scan was available, were included the current study. presence defined imaging using cut-off values total cross-sectional muscle tissue measured transversely at third lumbar level.A number 120 eligible analysis. Almost half (N = 54, 45 %) classified as having sarcopenia; 24 sarcopenic (44 had overweight 5 (9 obese. Overall morbidity mortality rate did not differ significantly between non-sarcopenic patients, nor overall or disease-free survival. Also obesity worse outcome.The negative short- selected group esophageal esophagectomy.